ArticleTherapeutic advances in drug safety2026
Prevalence of potentially inappropriate medication use and its association with hospitalization among older adults with chronic disease in the Amhara region, Ethiopia: a multicenter prospective cohort study.
Article in Therapeutic advances in drug safety, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Potentially inappropriate medications (PIMs) are common among older adults with chronic diseases and are linked to adverse outcomes, including hospitalization. Evidence on PIM prevalence and its clinical impact in Ethiopia is limited. This study assessed the prevalence of PIM use and its association with hospitalization among older adults in the Amhara Region, Ethiopia. Objectives: To determine the prevalence of PIM use and identify factors associated with PIM exposure and hospitalization in older adults with chronic diseases. Design: Multicenter prospective cohort study. Methods: Between May 1 and November 30, 2024, 1700 adults aged ⩾60 years were enrolled from five comprehensive specialized hospitals in the Amhara region. PIM use was assessed using the 2023 American Geriatrics Society Beers criteria. Sociodemographic, clinical, medication, and hospitalization data were collected via structured interviews and medical chart reviews. Multivariable logistic regression identified factors independently associated with PIM use and hospitalization. Results: PIM use was identified in 41.1% of participants. Exposure to PIMs significantly increased the risk of hospitalization (adjusted odds ratio (AOR) = 3.70, 95% confidence interval (CI): 2.25-4.95, Conclusion: PIM use is highly prevalent among older adults with chronic diseases in the Amhara Region and is associated with increased hospitalization risk. Systematic medication reviews and improved prescribing practices are essential to enhance medication safety and reduce preventable hospital admissions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.